Electrocardiographic and cardiovascular diagnostic characteristics of patients receiving long-term opioid therapy for pain

Journal of Opioid Management

Volumn 10, Issue 2, 2014, Pages 103-109

  Mason, Jay W ^a   Schwertschlag, Ullrich S ^b   Klutzaritz, Vicki ^b   Canafax, Daniel M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b THERAVANCE INC   (United States)

Author keywords

Arrhythmias; Chronic pain; Electrocardiogram; Myocardial infarction; Opioids

Indexed keywords

CODEINE; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PETHIDINE; TAPENTADOL; TRAMADOL;

ADULT; ARTICLE; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CHRONIC PAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; ECG ABNORMALITY; ELECTROCARDIOGRAPH; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; QRS COMPLEX; QT PROLONGATION;

ADULT; ANALGESICS, OPIOID; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PAIN; RETROSPECTIVE STUDIES;

EID: 84899841290     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2014.0199     Document Type: Article

References (34)

1. Carman WJ, Su S, Cook SF, et al.: Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort. Pharmacoepidemiol Drug Saf. 2011; 20(7): 754-762.
2. Gomes T, Mamdani MM, Dhalla IA, et al.: Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171(7): 686-691.
3. Khademi H, Malekzadeh R, Pourshams A, et al.: Opium use and mortality in Golestan Cohort Study: Prospective cohort study of 50,000 adults in Iran. BMJ. 2012; 344: e2502.
4. Solomon DH, Rassen JA, Glynn RJ, et al.: The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010; 170(22): 1979-1986.
5. Solomon DH, Rassen JA, Glynn RJ, et al.: The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010; 170(22): 1968-1976.
6. Anchersen K, Hansteen V, Gossop M, et al.: Opioid maintenance patients with QTc prolongation: Congenital long QT syndrome mutation may be a contributing risk factor. Drug Alcohol Depend. 2010; 112(3): 216-219.
7. Baker JR, Best AM, Pade PA, et al.: Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients. Ann Pharmacother. 2006; 40(3): 392-396.
8. Baker WA, Krantz MJ: QTc interval prolongation and opioid addiction therapy. Arch Intern Med. 2008; 168(14): 1592.
9. Demarie D, Marietta G, Imazio M, et al.: Cardiovascular-associated disease in an addicted population: An observation study. J Cardiovasc Med (Hagerstown). 2011; 12(1): 51-54.
10. Martell BA, Arnsten JH, Krantz MJ, et al.: Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol. 2005; 95(7): 915-918. (Pubitemid 40386816)
11. Wallner C, Stollberger C, Hlavin A, et al.: Electrocardiographic abnormalities in opiate addicts. Addiction. 2008; 103(12): 1987-1993.
12. Wedam EF, Bigelow GE, Johnson RE, et al.: QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med. 2007; 167(22): 2469-2475. (Pubitemid 350254906)
13. Mason JW, Ramseth DJ, Chanter DO, et al.: Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. J Electrocardiol. 2007; 40(3): 228-234.
14. Fridericia LS: The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease. Acta Med Scand. 1920; 53: 469-486.
15. Fanoe S, Jensen GB, Sjogren P, et al.: Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol. 2009; 67(2): 172-179.
16. Fredheim OM, Borchgrevink PC, Hegrenaes L, et al.: Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study. J Pain Symptom Manage. 2006; 32(2): 180-185. (Pubitemid 44131648)
17. Hanon S, Seewald RM, Yang F, et al.: Ventricular arrhythmias in patients treated with methadone for opioid dependence. J Interv Card Electrophysiol. 2010; 28(1): 19-22.
18. CredibleMeds.org: Available at http://crediblemeds.org/everyone/ composite-list-all-qtdrugs/?rf=All. Accessed January 23, 2014.
19. Raffa RB, Burmeister JJ, Yuvasheva E, et al.: QTc interval prolongation by d-propoxyphene: What about other analgesics? Expert Opin Pharmacother. 2012; 13(10): 1397-1409.
20. Katchman AN, McGroary KA, Kilborn MJ, et al.: Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 2002; 303(2): 688-694. (Pubitemid 35231242)
21. Roden DM, Yang T: Protecting the heart against arrhythmias: Potassium current physiology and repolarization reserve. Circulation. 2005; 112(10): 1376-1378. (Pubitemid 41291759)
22. Fryer RM, Hsu AK, Nagase H, et al.: Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther. 2000; 294(2): 451-457. (Pubitemid 30490815)
23. Lasukova TV, Rebrova TY, Tam SV: Activation of mu-opiate receptors as a factor of regulation of heart resistance to ischemia-reperfusion and oxidative stress. Bull Exp Biol Med. 2000; 130(8): 752-755. (Pubitemid 32140517)
24. Maslov LN, Krylatov AV, Lishmanov Iu B, et al.: The anti-arrhythmia properties of the functional opioid agonist orphanin FQ (nociceptin). Eksp Klin Farmakol. 1999; 62(5): 21-24.
25. Okubo S, Tanabe Y, Takeda K, et al.: Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: Role of delta-opioid receptor. Am J Physiol Heart Circ Physiol. 2004; 287(4): H1786-H1791. (Pubitemid 39313287)
26. Pagel PS, Krolikowski JG, Amour J, et al.: Morphine reduces the threshold of helium preconditioning against myocardial infarction: The role of opioid receptors in rabbits. J Cardiothorac Vasc Anesth. 2009; 23(5): 619-624.
27. Rebrova TY, Maslov LN, Lishmanov AY, et al.: Stimulation of mu and delta-opiate receptors and tolerance of isolated heart to oxidative stress: The role of NO-synthase. Biochemistry (Mosc). 2001; 66(4): 422-428.
28. Sigg DC, Coles JA Jr, Oeltgen PR, et al.: Role of delta-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol. 2002; 282(6): H1953-H1960. (Pubitemid 34663000)
29. Weihrauch D, Krolikowski JG, Bienengraeber M, et al.: Morphine enhances isoflurane-induced postconditioning against myocardial infarction: The role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg. 2005; 101(4): 942-949. (Pubitemid 41383051)
30. Yu XC, Wang HX, Pei JM, et al.: Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: Involvement of a cAMP-dependent pathway. J Mol Cell Cardiol. 1999; 31(10): 1809-1819.
31. Lee AY, Chen YT, Kan MN, et al.: Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease. Cardiovasc Res. 1992; 26(4): 392-395.
32. Machuganska A, Somova L, Dashev G, et al.: Opioid peptides in experimental myocardial infarction. I. The effect of naloxone. Acta Physiol Pharmacol Bulg. 1987; 13(1): 26-34. (Pubitemid 17075706)
33. Murphy GS, Szokol JW, Marymont JH, et al.: Opioids and cardioprotection: The impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2006; 20(4): 493-502. (Pubitemid 44119262)
34. Saybolt MD, Alter SM, Dos Santos F, et al.: Naloxone in cardiac arrest with suspected opioid overdoses. Resuscitation. 2010; 81(1):42-46.